Filed: 11/17/2025ACC: 0001636587-25-000060
📋 What this filing means
ACORN CAPITAL ADVISORS, LLC filed this quarterly 13F‑HR report disclosing 20 equity positions with a total reported market value of $196.99M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
20
Positions
$196.99M
Total AUM (reported)
31.95M
Total Shares
Allocation by class
COM$176.52M89.6%
CLASS A COM$7.81M4.0%
COM STK$7.62M3.9%
COM NEW$4.31M2.2%
COMMON STOCK$733.5K0.4%
Portfolio Concentration
Top 3$92.65M47.0%
4–10$80.06M40.6%
11–25$24.28M12.3%
Top 3 weight
47.0%
Top 10 weight
87.7%
Voting Authority Distribution
Total shares with voting rights: 31.95M
Sole
Full voting authority
31.95M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole20
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings20
Rows:
CG ONCOLOGY INC
SOLEShares1.13M
TypeSH
Market value$45.58M
23.14%
Sole
1.13M
Shared
0.00
None
0.00
UROGEN PHARMA LTD
SOLEShares1.26M
TypeSH
Market value$25.13M
12.76%
Sole
1.26M
Shared
0.00
None
0.00
PUMA BIOTECHNOLOGY INC
SOLEShares4.13M
TypeSH
Market value$21.94M
11.14%
Sole
4.13M
Shared
0.00
None
0.00
TREVI THERAPEUTICS INC
SOLEShares2.14M
TypeSH
Market value$19.63M
9.96%
Sole
2.14M
Shared
0.00
None
0.00
TERNS PHARMACEUTICALS INC
SOLEShares1.97M
TypeSH
Market value$14.80M
7.52%
Sole
1.97M
Shared
0.00
None
0.00
CANDEL THERAPEUTICS INC
SOLEShares2.58M
TypeSH
Market value$13.16M
6.68%
Sole
2.58M
Shared
0.00
None
0.00
BICARA THERAPEUTICS
SOLEShares643.38K
TypeSH
Market value$10.16M
5.16%
Sole
643.38K
Shared
0.00
None
0.00
ONKURE THERAPEUTICS INC
SOLEShares2.84M
TypeSH
Market value$7.81M
3.96%
Sole
2.84M
Shared
0.00
None
0.00
PROTARA THERAPEUTICS INC
SOLEShares1.75M
TypeSH
Market value$7.62M
3.87%
Sole
1.75M
Shared
0.00
None
0.00
VERASTEM INC
SOLEShares779.50K
TypeSH
Market value$6.88M
3.49%
Sole
779.50K
Shared
0.00
None
0.00
CYBIN INC
SOLEShares734.39K
TypeSH
Market value$4.31M
2.19%
Sole
734.39K
Shared
0.00
None
0.00
CARDIF ONCOLOGY INC
SOLEShares1.96M
TypeSH
Market value$4.04M
2.05%
Sole
1.96M
Shared
0.00
None
0.00
AURA BIOSCIENCES INC
SOLEShares595.74K
TypeSH
Market value$3.68M
1.87%
Sole
595.74K
Shared
0.00
None
0.00
BIOATLA INC
SOLEShares4.84M
TypeSH
Market value$3.34M
1.69%
Sole
4.84M
Shared
0.00
None
0.00
JASPER THERAPEUTICS
SOLEShares1.38M
TypeSH
Market value$3.29M
1.67%
Sole
1.38M
Shared
0.00
None
0.00
WHITEHAWK THERAPEUTICS INC
SOLEShares1.14M
TypeSH
Market value$2.16M
1.10%
Sole
1.14M
Shared
0.00
None
0.00
Q32 BIO INC.
SOLEShares803.42K
TypeSH
Market value$1.59M
0.81%
Sole
803.42K
Shared
0.00
None
0.00
X4 PHARMACEUTICALS INC
SOLEShares273.35K
TypeSH
Market value$934.9K
0.47%
Sole
273.35K
Shared
0.00
None
0.00
ACRIVON THERAPEUTICS INC
SOLEShares405.24K
TypeSH
Market value$733.5K
0.37%
Sole
405.24K
Shared
0.00
None
0.00
VYNE THERAPEUTICS INC
SOLEShares586.57K
TypeSH
Market value$199.4K
0.10%
Sole
586.57K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CG ONCOLOGY INCSOLE | COM | 1.13M | SH | $45.58M 23.14% | 1.13M | 0.00 | 0.00 |
UROGEN PHARMA LTDSOLE | COM | 1.26M | SH | $25.13M 12.76% | 1.26M | 0.00 | 0.00 |
PUMA BIOTECHNOLOGY INCSOLE | COM | 4.13M | SH | $21.94M 11.14% | 4.13M | 0.00 | 0.00 |
TREVI THERAPEUTICS INCSOLE | COM | 2.14M | SH | $19.63M 9.96% | 2.14M | 0.00 | 0.00 |
TERNS PHARMACEUTICALS INCSOLE | COM | 1.97M | SH | $14.80M 7.52% | 1.97M | 0.00 | 0.00 |
CANDEL THERAPEUTICS INCSOLE | COM | 2.58M | SH | $13.16M 6.68% | 2.58M | 0.00 | 0.00 |
BICARA THERAPEUTICSSOLE | COM | 643.38K | SH | $10.16M 5.16% | 643.38K | 0.00 | 0.00 |
ONKURE THERAPEUTICS INCSOLE | CLASS A COM | 2.84M | SH | $7.81M 3.96% | 2.84M | 0.00 | 0.00 |
PROTARA THERAPEUTICS INCSOLE | COM STK | 1.75M | SH | $7.62M 3.87% | 1.75M | 0.00 | 0.00 |
VERASTEM INCSOLE | COM | 779.50K | SH | $6.88M 3.49% | 779.50K | 0.00 | 0.00 |
CYBIN INCSOLE | COM NEW | 734.39K | SH | $4.31M 2.19% | 734.39K | 0.00 | 0.00 |
CARDIF ONCOLOGY INCSOLE | COM | 1.96M | SH | $4.04M 2.05% | 1.96M | 0.00 | 0.00 |
AURA BIOSCIENCES INCSOLE | COM | 595.74K | SH | $3.68M 1.87% | 595.74K | 0.00 | 0.00 |
BIOATLA INCSOLE | COM | 4.84M | SH | $3.34M 1.69% | 4.84M | 0.00 | 0.00 |
JASPER THERAPEUTICSSOLE | COM | 1.38M | SH | $3.29M 1.67% | 1.38M | 0.00 | 0.00 |
WHITEHAWK THERAPEUTICS INCSOLE | COM | 1.14M | SH | $2.16M 1.10% | 1.14M | 0.00 | 0.00 |
Q32 BIO INC.SOLE | COM | 803.42K | SH | $1.59M 0.81% | 803.42K | 0.00 | 0.00 |
X4 PHARMACEUTICALS INCSOLE | COM | 273.35K | SH | $934.9K 0.47% | 273.35K | 0.00 | 0.00 |
ACRIVON THERAPEUTICS INCSOLE | COMMON STOCK | 405.24K | SH | $733.5K 0.37% | 405.24K | 0.00 | 0.00 |
VYNE THERAPEUTICS INCSOLE | COM | 586.57K | SH | $199.4K 0.10% | 586.57K | 0.00 | 0.00 |